Shows
AudioMedica NewsNeoadjuvant PD-1 Blockade Enables Patients with Mismatch Repair Deficient Colorectal Cancers to Avoid SurgeryAn interview with:
Andrea Cercek MD, Gastrointestinal Cancer Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York
And:
Ryan B Corcoran MD PhD, Director of the GI Cancer Program, Massachusetts General Hospital Cancer Center, Boston MA
CHICAGO—The Audio Journal of …2025-05-0314 min
AudioMedica NewsTwo Checkpoint Inhibitors in One Bispecific Molecule Improved Survival in Patients with High-Risk Gastric CancerAn interview with:
Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China
Sarah Maxwell, Audio Journal of …2025-04-2310 min
AudioMedica NewsHow Babies Use Object Permanence To Get What They WantHow Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA, Associate Professor in the Department of Physical Therapy at Rangos School of Health Sciences, in …2022-08-0400 minAudioMedica NewsHow Babies Use Object Permanence To Get What They WantHow Babies Use Object Permanence To Get What They Want 2022: A report from the journal: Pediatric Physical Therapy Regina Harbourne PhD, PT, PCS, FAPTA, Associate Professor in the Department of Physical Therapy at Rangos School of Health Sciences, in …2022-08-0400 min
AudioMedica NewsWhich Tasks Most Influence Pediatric PT Productivity, Effectiveness?From: January 2020 Edition of Pediatric Physical Therapy journal:
CINCINNATI—Julie Badylak PT and Rebecca Durham Reder OTD, OTR/L from Cincinnati Children’s Hospital discuss the findings of their team’s report in the journal Pediatric Physical Therapy on the assessment of tasks …2019-12-3151 minAudioMedica NewsWhich Tasks Most Influence Pediatric PT Productivity, Effectiveness?From: January 2020 Edition of Pediatric Physical Therapy journal:
CINCINNATI—Julie Badylak PT and Rebecca Durham Reder OTD, OTR/L from Cincinnati Children’s Hospital discuss the findings of their team’s report in the journal Pediatric Physical Therapy on the assessment of tasks …2019-12-3151 min
AudioMedica NewsCan Initial Radiotherapy Improve Survival with Prostate Cancer?CHICAGO—Patients with newly-diagnosed hormone-sensitive metastatic prostate cancer (mPC) who had prostate radiotherapy (RT) before their androgen deprivation therapy (ADT) lived longer than those treated with standard ADT alone in a retrospective analysis—the largest single-center experience to date of primary tumor-directed …2018-07-2030 minAudioMedica NewsCan Initial Radiotherapy Improve Survival with Prostate Cancer?CHICAGO—Patients with newly-diagnosed hormone-sensitive metastatic prostate cancer (mPC) who had prostate radiotherapy (RT) before their androgen deprivation therapy (ADT) lived longer than those treated with standard ADT alone in a retrospective analysis—the largest single-center experience to date of primary tumor-directed …2018-07-2030 min
AudioMedica NewsGeriatric Assessment Improved Outcomes for Older Patients with CancerCHICAGO—A “cluster randomized controlled trial” of treatment for patients with advanced cancers found that the use of standardized geriatric assessments significantly increased the number and quality of discussions about age-related concerns in comparison with usual care and also resulted in …2018-07-1110 minAudioMedica NewsGeriatric Assessment Improved Outcomes for Older Patients with CancerCHICAGO—A “cluster randomized controlled trial” of treatment for patients with advanced cancers found that the use of standardized geriatric assessments significantly increased the number and quality of discussions about age-related concerns in comparison with usual care and also resulted in …2018-07-1110 min
AudioMedica NewsSubcutaneous Daratumumab “Potential Game Changer” for Multiple MyelomaATLANTA—Subcutaneous administration of the anti-CD 38 monoclonal antibody daratumumab could help more patients get this emerging therapy more easily for their advanced or recently-diagnosed multiple myeloma according to research reported from the Pavo study at the 2017 American Society of …2018-01-1506 minAudioMedica NewsSubcutaneous Daratumumab “Potential Game Changer” for Multiple MyelomaATLANTA—Subcutaneous administration of the anti-CD 38 monoclonal antibody daratumumab could help more patients get this emerging therapy more easily for their advanced or recently-diagnosed multiple myeloma according to research reported from the Pavo study at the 2017 American Society of …2018-01-1506 min
AudioMedica NewsProstate Genomics—Which Patients Will Die?MILAN, Italy—Genomic profiling could help reduce the risk of over-treatment in primary prostate cancer (PC) by identifying patients and healthy individuals whose genes put them at greatest risk of developing dangerous disseminated disease said Norman J Maitland PhD, Professor of …2017-04-2030 minAudioMedica NewsProstate Genomics—Which Patients Will Die?MILAN, Italy—Genomic profiling could help reduce the risk of over-treatment in primary prostate cancer (PC) by identifying patients and healthy individuals whose genes put them at greatest risk of developing dangerous disseminated disease said Norman J Maitland PhD, Professor of …2017-04-2030 min
AudioMedica NewsGene Assay Predicts Which Patients Need Radiation After ProstatectomyARTICLE
MILAN, Italy—Genomic testing combined with clinical assessment could be the best way to identify patients with prostate cancer who can benefit from early radiotherapy after prostatectomy, according to a study in The Lancet Oncology reported at the European Multidisciplinary …2017-04-1830 minAudioMedica NewsGene Assay Predicts Which Patients Need Radiation After ProstatectomyARTICLE
MILAN, Italy—Genomic testing combined with clinical assessment could be the best way to identify patients with prostate cancer who can benefit from early radiotherapy after prostatectomy, according to a study in The Lancet Oncology reported at the European Multidisciplinary …2017-04-1830 min
AudioMedica NewsActive Surveillance Better for Which Renal Cell Cancers?April 15, 2017
Active Surveillance for Renal Cell Cancer
MILAN, Italy—Criteria for withholding aggressive therapies early in the course of renal cell cancer were updated at the 2016 European Multidisciplinary Meeting on Urological Cancers (EMUC) by Phillip M Pierorazio …2017-04-1830 minAudioMedica NewsActive Surveillance Better for Which Renal Cell Cancers?April 15, 2017
Active Surveillance for Renal Cell Cancer
MILAN, Italy—Criteria for withholding aggressive therapies early in the course of renal cell cancer were updated at the 2016 European Multidisciplinary Meeting on Urological Cancers (EMUC) by Phillip M Pierorazio …2017-04-1830 min
AudioMedica NewsNuclear War: The Facts TodayHans Kristensen, Director of the Nuclear Information Project, Federation of American Scientists, Washington DC and co-author of “The Growing Threat of Nuclear War and the Role of the Health Community” (World Medical Journal, 2016) tells Peter Goodwin why we need …2017-02-0919 minAudioMedica NewsNuclear War: The Facts TodayHans Kristensen, Director of the Nuclear Information Project, Federation of American Scientists, Washington DC and co-author of “The Growing Threat of Nuclear War and the Role of the Health Community” (World Medical Journal, 2016) tells Peter Goodwin why we need …2017-02-0919 min
AudioMedica NewsCompetitive and Leisure Sports: Recommendations to Minimise Cardiovascular RiskAudio Journal of Cardiovascular Medicine
Reporting from: 2016 European Society of Cardiology, Rome
Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk
ROME—Exercise benefits most patients with cardiovascular disease who can take part in leisure sports safely if they wish, …2016-08-2807 minAudioMedica NewsCompetitive and Leisure Sports: Recommendations to Minimise Cardiovascular RiskAudio Journal of Cardiovascular Medicine
Reporting from: 2016 European Society of Cardiology, Rome
Competitive and Leisure Sports: Recommendations to Minimise Cardiovascular Risk
ROME—Exercise benefits most patients with cardiovascular disease who can take part in leisure sports safely if they wish, …2016-08-2807 min
AudioMedica NewsYoung Women with HER2+ Early Breast Cancer Better with MastectomyAudio Journal of Oncology
Young Patients With Early Breast Cancer Live Longer With Mastectomy
September 1, 2016
Transcript of the podcast as broadcast:
PETER GOODWIN: Younger women with early breast cancer treated with mastectomy had lower mortality at 20 years …2016-08-2409 minAudioMedica NewsYoung Women with HER2+ Early Breast Cancer Better with MastectomyAudio Journal of Oncology
Young Patients With Early Breast Cancer Live Longer With Mastectomy
September 1, 2016
Transcript of the podcast as broadcast:
PETER GOODWIN: Younger women with early breast cancer treated with mastectomy had lower mortality at 20 years …2016-08-2409 min
AudioMedica NewsChimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemiaWASHINGTON DC—A new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no other options to prevent the progress of this fatal phase of the disease. At the American Association for Cancer Research…2013-08-0600 minAudioMedica NewsChimeric antigen receptor T-cell therapy rescues kids with relapsing acute lymphoblastic leukaemiaWASHINGTON DC—A new type of immunotherapy has brought responses in children with acute lymphoblastic leukaemia in relapse who had no other options to prevent the progress of this fatal phase of the disease. At the American Association for Cancer Research…2013-08-0600 min
AudioMedica NewsTwo-step immunotherapy brings promise in advanced ovarian cancerWASHINGTON DC—A new type of immunotherapy has helped patients with advanced ovarian cancer who had no other therapeutic options. In a study reported to the 2013 conference of the American Association for Cancer Research Dr Lana Kandalaft from…2013-04-0800 minAudioMedica NewsTwo-step immunotherapy brings promise in advanced ovarian cancerWASHINGTON DC—A new type of immunotherapy has helped patients with advanced ovarian cancer who had no other therapeutic options. In a study reported to the 2013 conference of the American Association for Cancer Research Dr Lana Kandalaft from…2013-04-0800 min
AudioMedica NewsCirculating free tumour DNA test could guide breast cancer therapyCAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Institute at Cambridge University report in the New England Journal of Medicine that …2013-04-0300 minAudioMedica NewsCirculating free tumour DNA test could guide breast cancer therapyCAMBRIDGE, UK—A new blood test promises quicker assessment of treatment efficacy in patients with metastatic breast cancer. Dr Dana Tsui and colleagues from the Cancer Research UK Institute at Cambridge University report in the New England Journal of Medicine that …2013-04-0300 min
AudioMedica NewsDog walking cuts breast cancer recurrence riskWalking a dog most days could cut down your risk of having a recurrence of breast cancer, according to research presented at the St Gallen conference on Primary Therapy of Early Breast Cancer in Switzerland — where delegates also heard …2013-03-2900 minAudioMedica NewsDog walking cuts breast cancer recurrence riskWalking a dog most days could cut down your risk of having a recurrence of breast cancer, according to research presented at the St Gallen conference on Primary Therapy of Early Breast Cancer in Switzerland — where delegates also heard …2013-03-2900 min
AudioMedica NewsWhich patients for bisphosphonate control of breast cancer metastasis?ST GALLEN, SWITZERLAND—Bisphosphonates have an important part to play in managing breast cancer according to research reported at the 2013 St Gallen conference on “Primary Therapy of Early Breast Cancer”. Professor Robert Coleman…2013-03-2900 minAudioMedica NewsWhich patients for bisphosphonate control of breast cancer metastasis?ST GALLEN, SWITZERLAND—Bisphosphonates have an important part to play in managing breast cancer according to research reported at the 2013 St Gallen conference on “Primary Therapy of Early Breast Cancer”. Professor Robert Coleman…2013-03-2900 min
AudioMedica NewsIs breast cancer screening oversold?ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of the University of Texas M D Anderson Cancer Center in Houston. While …2013-03-2900 minAudioMedica NewsIs breast cancer screening oversold?ST GALLEN, SWITZERLAND—The controversy about the effectiveness of mammographic screening was aired at the 2013 conference on “Primary Therapy of Early Breast Cancer” by Dr Donald Berry of the University of Texas M D Anderson Cancer Center in Houston. While …2013-03-2900 min
AudioMedica NewsLow risk prostate cancer: scope and benefits from reducing overtreatmentORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital, the Dana-Farber Cancer Institute and Harvard University in Boston, MA — a …2013-03-2400 minAudioMedica NewsLow risk prostate cancer: scope and benefits from reducing overtreatmentORLANDO, FLORIDA—Patients with low-risk prostate cancer are more likely to die with their disease than of it, according to Dr Ayal Aizer from the Brigham and Women’s Hospital, the Dana-Farber Cancer Institute and Harvard University in Boston, MA — a …2013-03-2400 min
AudioMedica NewsEnzalutamide in metastatic castration resistant prostate cancer: over 75s benefit tooORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM study reported at the 2013 Genitourinary Cancers…2013-03-2400 minAudioMedica NewsEnzalutamide in metastatic castration resistant prostate cancer: over 75s benefit tooORLANDO, FLORIDA—Men over 75 were safely and effectively treated for their metastatic castration-resistant prostate cancer with the androgen receptor inhibitor enzalutamide in the Phase III AFFIRM study reported at the 2013 Genitourinary Cancers…2013-03-2400 min
AudioMedica NewsLow risk localized prostate cancer: no harm from waiting!ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Symposium by Dr Andrew Loblaw from the Sunnybrook Health Sciences Centre …2013-03-2400 minAudioMedica NewsLow risk localized prostate cancer: no harm from waiting!ORLANDO, FLORIDA—A decision to delay surgery or radiotherapy for early prostate cancer is in the best interests of most patients according to research presented to the 2013 Genitourinary Cancers Symposium by Dr Andrew Loblaw from the Sunnybrook Health Sciences Centre …2013-03-2400 min
AudioMedica NewsAndrogen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancerORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months — but have fewer side effects — according to study findings announced at the 2013 ASCO …2013-03-2400 minAudioMedica NewsAndrogen blockade: 18 as good as 36 months in radiotherapy-treated prostate cancerORLANDO, FLORIDA—Patients receiving radiotherapy for high-risk node-negative prostate cancer benefit as much from 18 months of androgen blockade as from the usual 36 months — but have fewer side effects — according to study findings announced at the 2013 ASCO …2013-03-2400 min
AudioMedica NewsMDFM Christmas Edition: Best of 2012– HTA: Renal denervation lowers blood pressure independently of drugs
Other headlines
– CML:patients with T 315 I mutation respond to ponatinib
– Eat, drink and be merry: tomorrow you won’t die if you take exercise.
[audio:https://www.audiomedica.com/podcasting/mdfm/121227ChristmasMDFMLoRes.mp3]…2012-12-3100 minAudioMedica NewsMDFM Christmas Edition: Best of 2012– HTA: Renal denervation lowers blood pressure independently of drugs
Other headlines
– CML:patients with T 315 I mutation respond to ponatinib
– Eat, drink and be merry: tomorrow you won’t die if you take exercise.
[audio:https://www.audiomedica.com/podcasting/mdfm/121227ChristmasMDFMLoRes.mp3]…2012-12-3100 min
AudioMedica NewsYoung adults less likely to be diagnosed with hypertension than over 60sLOS ANGELES—Half of young adults who had multiple, elevated, blood pressure results on recent outpatient visits to the doctor, went home without a hypertension diagnosis. Research presented at the 2012 American Heart Association meeting showed, after four years of trips …2012-12-3100 minAudioMedica NewsYoung adults less likely to be diagnosed with hypertension than over 60sLOS ANGELES—Half of young adults who had multiple, elevated, blood pressure results on recent outpatient visits to the doctor, went home without a hypertension diagnosis. Research presented at the 2012 American Heart Association meeting showed, after four years of trips …2012-12-3100 min
AudioMedica NewsMore cardiac deaths in the winter — no matter the climateLOS ANGELES—Regardless of climate, there are more deaths from heart-related issues in winter-time than in the summer. Results from a 12-year US population based study with over 220,000 people were presented at the American Heart Association meeting in Los Angeles …2012-12-3100 minAudioMedica NewsMore cardiac deaths in the winter — no matter the climateLOS ANGELES—Regardless of climate, there are more deaths from heart-related issues in winter-time than in the summer. Results from a 12-year US population based study with over 220,000 people were presented at the American Heart Association meeting in Los Angeles …2012-12-3100 min
AudioMedica NewsAging signs predict coronary risk independently of chronological ageLOS ANGELES—Looking older than your chronological age is a risk factor for cardiovascular disease — at least among white Caucasians — according to a study of over ten thousand Danish people from the general population who were…2012-12-3100 minAudioMedica NewsAging signs predict coronary risk independently of chronological ageLOS ANGELES—Looking older than your chronological age is a risk factor for cardiovascular disease — at least among white Caucasians — according to a study of over ten thousand Danish people from the general population who were…2012-12-3100 min
AudioMedica NewsUK TACT2 trial confirms chemotherapy is highly effective in early beast cancerSAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer, has confirmed that modern chemotherapy is very effective, and continues to contribute to very high cure rates. Professor David Cameron of Edinburgh University explains …2012-12-1900 minAudioMedica NewsUK TACT2 trial confirms chemotherapy is highly effective in early beast cancerSAN ANTONIO, TEXAS—The UK TACT2 trial, looking at over 4 000 patients with early breast cancer, has confirmed that modern chemotherapy is very effective, and continues to contribute to very high cure rates. Professor David Cameron of Edinburgh University explains …2012-12-1900 min
AudioMedica NewsChronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutationATLANTA, GEORGIA—A “third generation” tyrosine kinase inhibitor — ponatinib — has succeeded in controlling chronic myeloid leukaemia and Philadelphia-positive acute lymphoblastic leukaemia in patients who have the feared T 315 I mutation — which has prevented…2012-12-1900 minAudioMedica NewsChronic myeloid leukaemia: third generation TKI, ponatinib, succeeds against the T 315 I mutationATLANTA, GEORGIA—A “third generation” tyrosine kinase inhibitor — ponatinib — has succeeded in controlling chronic myeloid leukaemia and Philadelphia-positive acute lymphoblastic leukaemia in patients who have the feared T 315 I mutation — which has prevented…2012-12-1900 min
AudioMedica NewsYounger than 35 with breast cancer: always consider neoadjuvant chemotherapySAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German Breast Group presented at the 2012 San Antonio …2012-12-1900 minAudioMedica NewsYounger than 35 with breast cancer: always consider neoadjuvant chemotherapySAN ANTONIO, TEXAS—Women with breast cancer under the age of 35 respond very well to neo-adjuvant chemotherapy as the first line of attack against their disease, according to research from the German Breast Group presented at the 2012 San Antonio …2012-12-1900 min
AudioMedica NewsAcute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?ATLANTA, GEORGIA—Arsenic could play a key role in perfecting gentle but curative regimens for acute promyelocytic leukaemia, according to Italian researchers reporting to the 2012 American Society of Hematology annual meeting. Professor Francesco Lo Coco…2012-12-1800 minAudioMedica NewsAcute promyelocytic leukaemia: arsenic better than chemotherapy to combine with retinoic acid?ATLANTA, GEORGIA—Arsenic could play a key role in perfecting gentle but curative regimens for acute promyelocytic leukaemia, according to Italian researchers reporting to the 2012 American Society of Hematology annual meeting. Professor Francesco Lo Coco…2012-12-1800 min
AudioMedica NewsNew drug looks very promising in high risk chronic lymphocytic leukaemiaATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with chronic lymphocytic leukaemia—according to research presented at the American Society of Hematology annual meeting. Dr Jan Burger from the MD Anderson Cancer Center…2012-12-1100 minAudioMedica NewsNew drug looks very promising in high risk chronic lymphocytic leukaemiaATLANTA, GEORGIA—The new tyrosine kinase ibrutinib has shown “profound activity” in patients with chronic lymphocytic leukaemia—according to research presented at the American Society of Hematology annual meeting. Dr Jan Burger from the MD Anderson Cancer Center…2012-12-1100 min
AudioMedica NewsLocal or regional breast cancer recurrences mandate adjuvant chemotherapySAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and…2012-12-1100 minAudioMedica NewsLocal or regional breast cancer recurrences mandate adjuvant chemotherapySAN ANTONIO, TEXAS—Patients with local or regional recurrences of breast cancer, should be treated with chemotherapy as well as surgery and…2012-12-1100 min
AudioMedica NewsLowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study findingATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published in the…2012-12-1100 minAudioMedica NewsLowering hematocrit below 45 per cent protects against clotting risk in patients with polycythemia vera — randomized study findingATLANTA, GA—Solid confirmation of target hematocrit to minimise clotting risks in polycythemia vera has been presented at the American Society of Hematology annual meeting and simultaneously published in the…2012-12-1100 min
AudioMedica NewsBreast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapseSAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 4451 women with ten-year follow-up data presented …2012-12-1100 minAudioMedica NewsBreast cancer: less radiotherapy in fewer hospital visits is just as good for preventing relapseSAN ANTONIO, TEXAS—Three weeks of radiotherapy rather than five — and lower overall doses of radiation — were just has as effective for treating breast cancer in the UK START trial conducted among 4451 women with ten-year follow-up data presented …2012-12-1100 min
AudioMedica NewsDengue vaccine is safe and effective — but not against all virus serotypesATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne …2012-12-1100 minAudioMedica NewsDengue vaccine is safe and effective — but not against all virus serotypesATLANTA—Results from the first large study of a vaccine for dengue fever — in 4000 Thai children — show that it is safe to use and effective — raising immunity to three out of the four “serotypes” of this mosquito-borne …2012-12-1100 min
AudioMedica NewsSchistosomiasis: water, sanitation and hygiene together with donated praziquantel make elimination possibleATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in water-supply sanitation and hygiene and…2012-11-2700 minAudioMedica NewsSchistosomiasis: water, sanitation and hygiene together with donated praziquantel make elimination possibleATLANTA—Schistosomiasis — also known as bilharzia — could be eliminated from Africa and elsewhere by using two actions together: making simple improvements in water-supply sanitation and hygiene and…2012-11-2700 min
AudioMedica NewsMalaria vaccine prevents one third of malaria cases at 12 monthsATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Society of Tropical Medicine and Hygiene conference by …2012-11-2000 minAudioMedica NewsMalaria vaccine prevents one third of malaria cases at 12 monthsATLANTA—Efficacy of the RTS,S malaria vaccine for children — vaccinated between six and 12 weeks age — checked-in at around 30 per cent in preliminary findings from Africa released at the American Society of Tropical Medicine and Hygiene conference by …2012-11-2000 min
AudioMedica NewsGAUSS STUDY: New alternative for LDL lowering in patients intolerant to statinsLOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …2012-11-1600 minAudioMedica NewsGAUSS STUDY: New alternative for LDL lowering in patients intolerant to statinsLOS ANGELES—A more powerful back-up drug for patients intolerant to statins was announced at the American Heart Association 2012 Scientific Sessions. A monoclonal antibody called: AMG 145 against a protein found to regulate LDL receptor activity — the PCSK 9 …2012-11-1600 min
AudioMedica NewsPregnancy hormone helps hospitalised patients with acute heart failureLOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, according to findings discussed at the American Heart Association’s 2012 Scientific Sessions …2012-11-1600 minAudioMedica NewsPregnancy hormone helps hospitalised patients with acute heart failureLOS ANGELES—A recombinant form of the human hormone relaxin — active in pregnancy to optimise the mother’s cardiovascular capacity — may help patients hospitalised for acute heart failure, according to findings discussed at the American Heart Association’s 2012 Scientific Sessions …2012-11-1600 min
AudioMedica NewsDirect infusions of HDL to prevent re-infarction in patients with acute coronary syndromesLOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having another, according to conclusions from a …2012-11-1600 minAudioMedica NewsDirect infusions of HDL to prevent re-infarction in patients with acute coronary syndromesLOS ANGELES—Direct infusions of human HDL — to speedily boost HDL levels —could be an answer to preventing re-infarction in patients who’ve just had a heart attack and are at high risk of having another, according to conclusions from a …2012-11-1600 min
AudioMedica NewsImportant new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findingsLOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the American Heart…2012-11-1200 minAudioMedica NewsImportant new role for aspirin: prevention of recurrent thromboembolism: ASPIRE findingsLOS ANGELES—Aspirin has a new role: in preventing recurrent thromboembolism among patients who are not candidates for anti-coagulation — according to conclusions from the ASPIRE study reported to the American Heart…2012-11-1200 min
AudioMedica NewsPolypill—even better for coronary prevention among those at high riskLOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” …2012-11-1200 minAudioMedica NewsPolypill—even better for coronary prevention among those at high riskLOS ANGELES—The “polypill” — a multi-drug pill — combining diuretic, ACE inhibitor, beta-blocker, statin and aspirin — brings even more benefit when it’s targeted at patients who are at elevated coronary risk rather than being used as a general “insurance” …2012-11-1200 min
AudioMedica NewsCABG better than pci in patients with diabetes and multi-vessel coronary diseaseLOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Heart Association 2012 Scientific Sessions…2012-11-1000 minAudioMedica NewsCABG better than pci in patients with diabetes and multi-vessel coronary diseaseLOS ANGELES—The optimal revascularisation strategy for patients with diabetes and multi-vessel coronary disease was confirmed to be coronary artery bypass grafting rather than PCI at the American Heart Association 2012 Scientific Sessions…2012-11-1000 min
AudioMedica NewsBeyond Legs and Arms For Afghanistan: Disability A Resource Not A Liability
LONDON—A man with no legs and only one arm and a boy crippled by polio have been instrumental in steering a Red Cross team’s work in Afghanistan. The ICRC’s head of Orthopaedics in Kabul, Alberto Cairo, was invited by …2012-09-2500 minAudioMedica NewsBeyond Legs and Arms For Afghanistan: Disability A Resource Not A Liability
LONDON—A man with no legs and only one arm and a boy crippled by polio have been instrumental in steering a Red Cross team’s work in Afghanistan. The ICRC’s head of Orthopaedics in Kabul, Alberto Cairo, was invited by …2012-09-2500 min
AudioMedica NewsEthnic lifestyle and diet differences have a big impact on health
LONDON—The health impact of diet and physical activity may play a part in the marked ethnic differences in type 2 diabetes and cardiovascular disease in the UK according to research reported at the London School of Hygiene & Tropical Medicine. …2012-09-2400 minAudioMedica NewsEthnic lifestyle and diet differences have a big impact on health
LONDON—The health impact of diet and physical activity may play a part in the marked ethnic differences in type 2 diabetes and cardiovascular disease in the UK according to research reported at the London School of Hygiene & Tropical Medicine. …2012-09-2400 min
AudioMedica NewsPatient power improves health systems and saves cost
LONDON—People are now routinely using the internet to find out about health conditions and to share their own experiences with others with similar diagnoses. This is a radical change in how people experience illness. Health professionals and policy makers have …2012-09-2400 minAudioMedica NewsPatient power improves health systems and saves cost
LONDON—People are now routinely using the internet to find out about health conditions and to share their own experiences with others with similar diagnoses. This is a radical change in how people experience illness. Health professionals and policy makers have …2012-09-2400 min
AudioMedica NewsRio Conference on Sustainable Development: “Health Should Be Top Priority”
RIO DE JANEIRO and LONDON—A call for action on global health has been made in an article published by The Lancet medical journal about the United Nations Conference on Sustainable Development held in Rio de Janeiro. Issues which degrade the …2012-07-2900 minAudioMedica NewsRio Conference on Sustainable Development: “Health Should Be Top Priority”
RIO DE JANEIRO and LONDON—A call for action on global health has been made in an article published by The Lancet medical journal about the United Nations Conference on Sustainable Development held in Rio de Janeiro. Issues which degrade the …2012-07-2900 min
AudioMedica NewsFamily planning: central role in global development – Lancet series
LONDON—Family planning is a key priority for fulfilling global development goals, according to researchers writing in a special series of The Lancet medical journal coinciding with the London Summit on Family Planning. Peter Goodwin hears from one of the Lancet …2012-07-1000 min
AudioMedica NewsASCO 2012 ANNUAL MEETING: Outgoing ASCO President Michael Link Comments On Key New Clinical Research Findings
CHICAGO—The outgoing president of ASCO, Dr Michael Link from Stanford University School of Medicine in California, answers questions from Peter Goodwin about the progress achieved in cancer clinical science during his year in office. He talks specifically about new research …2012-06-1100 min